Clinical Scorecard: YUVEZZI Campaign Targets Presbyopia
At a Glance
| Category | Detail |
|---|---|
| Condition | Presbyopia |
| Key Mechanisms | Dual-agent ophthalmic solution containing carbachol and brimonidine tartrate. |
| Target Population | Adults with age-related blurry near vision, typically beginning around age 45. |
| Care Setting | Direct-to-consumer campaign for prescription eye drops. |
Key Highlights
- 0
- 1
- 2
- 3
- 4
Guideline-Based Recommendations
Diagnosis
- Presbyopia typically begins around age 45.
Management
- YUVEZZI is a once-daily prescription eye drop for treatment.
Monitoring & Follow-up
- Observe for common side effects such as headache and impaired vision.
Risks
- Temporary eye pain or irritation upon use.
Patient & Prescribing Data
Adults with age-related blurry near vision.
Available through e-pharmacy partner PHILRx or local retail pharmacies.
Clinical Best Practices
- 0
- 1
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
